Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 563

Document Document Title
WO/2010/151006
Provided are a novel organic electroluminescent compound and an organic electroluminescent device using the same. Since the organic electroluminescent compound disclosed herein exhibits good luminescence efficiency and excellent life pro...  
WO/2010/145696
The present invention relates to methods for detecting presence, or absence, of blood. Specifically, the present invention relates to methods for detecting the presence, or absence, of blood, comprising applying a solution comprising lum...  
WO/2010/147319
The present invention relates to an acridine derivative and to an organic electroluminescent element comprising the same. More specifically, the present invention relates to an acridine derived compound in which an acridine moiety and an...  
WO/2010/147319
The present invention relates to an acridine derivative and to an organic electroluminescent element comprising the same. More specifically, the present invention relates to an acridine derived compound in which an acridine moiety and an...  
WO/2010/062107
Provided is an electroluminescent device including an organic layer interposed between an anode and a cathode on a substrate, wherein the organic layer includes an electroluminescent layer containing one or more dopant compound(s) of for...  
WO/2010/050779
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices and organic solar cells comprising the same. The organic electroluminescent compounds according to the present invention exhibit high luminou...  
WO/2010/045270
The invention provides methods and compositions for detecting and measuring the amount of autophagosomes in cells or tissues, including biopsy samples, in vitro, in situ and/or in vivo. By detecting and measuring the amount of autophagos...  
WO/2010/045270
The invention provides methods and compositions for detecting and measuring the amount of autophagosomes in cells or tissues, including biopsy samples, in vitro, in situ and/or in vivo. By detecting and measuring the amount of autophagos...  
WO/2009/103798
The application relates to cationic compounds of formula (Ia) where R1 to R9 and X- are defined as indicated in claim 1. Said compounds, some of which have not yet been described in the prior art, are suitable for coloring keratinous fib...  
WO/2009/097433
There are described novel rhodamine dye compounds and imaging members and imaging methods, including thermal imaging members and imaging methods, utilizing the compounds. The dye compounds exhibit a first color when in the crystalline fo...  
WO/2009/067417
A method is provided for N-alkylation of acridine compounds, typically with a 1,3- propane sultone alkylating reagent, in ionic liquid solvents to provide the corresponding acridinium compounds in high yeild.  
WO/2009/041519
An organic-inorganic composite material capable of attaining a charge-separated state enhanced in life and stability as compared with that of conventional organic-inorganic composite materials, more particularly, an organic-inorganic com...  
WO/2009/030715
The invention relates tosubstitutedarylsulphonylaminomethylphosphonic acid derivativesof general formula (I) wherein the groups Ra to Rf, A and Z are defined as mentioned in the specification and claims, which are suitable for preparinga...  
WO/2009/026858
The invention relates to the synthesis and evaluation of novel organic products as anti-parasitic, anti-fungal and anti-viral agents. More specifically, the invention relates to novel derivatives of 10-alyl- (I), 10-(3methyl-2-butenyl)- ...  
WO/2008/124749
The present invention relates to methods and kits for detecting an analyte in a test sample using acridinium-9-carboxylate aryl esters.  
WO/2008/109840
This invention is directed to, for example, compounds of formula (I): wherein n, m, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically accep...  
WO/2008/068540
The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I), wherein R1-R5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which a...  
WO/2008/068540
The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I), wherein R1-R5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which a...  
WO/2008/067055
Chemiluminescent acridinium esters are provided which are fast light emitting and hydrolytically stable. The chemiluminescent acridinium esters are useful labels in assays for detecting or quantifying analytes.  
WO/2008/067055
Chemiluminescent acridinium esters are provided which are fast light emitting and hydrolytically stable. The chemiluminescent acridinium esters are useful labels in assays for detecting or quantifying analytes.  
WO/2008/064011
A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions and methods for their use to treat parasitic infections, such as malaria and to...  
WO/2008/012782
The present invention relates to the use of a compound of formula (I): in which R1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R2 and R3 represent, independently of one another, a hy...  
WO/2008/012782
The present invention relates to the use of a compound of formula (I): in which R1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R2 and R3 represent, independently of one another, a hy...  
WO/2008/011073
This invention provides nuclear hormone receptor binding compounds, compositions comprising the same and methods of uses thereof in treating a variety of diseases or conditions in a subject, including, inter-alia, prostate cancer and/or ...  
WO/2008/010984
This invention relates to the stabilization of p53 in cells, thereby inducing eitrher cell cycle arrest or apoptosis or both and the consequence of such stabilization on the treatment of cancer. Specifically, the use of acridine and its ...  
WO/2008/004529
A novel fluorescent amino acid derivative that can be synthesized through a simple process and that can be excited by visible rays, especially those of blue laser light region, exhibiting high photostability; and a process for producing ...  
WO/2007/136125
Disclosed are: a composition for inhibiting the transcription of an extracellular matrix gene, comprising a compound having a heterocyclic ring represented by the formula (I) and an inert carrier; and others.  
WO/2007/125952
Disclosed is a compound represented by the formula (I) below, a pharmaceutically acceptable salt thereof, or a solvate of any of them. (I) In the formula, R1 represents an optionally substituted lower alkyl group; Y represents -S(O)n- (w...  
WO/2007/110228
The present invention relates to N-heterocyclic compounds of the general formulae A, B, C and D and also to their uses in electronic, optoelectronic and electroluminescent components.  
WO/2007/104695
Novel quinolyl and acridinylhydrazone compounds of formula (I), which present remarkable biological activity especially against the choloroquine-resistant Plasmodium falciparum strains, useful for the treatment and prevention of malaria ...  
WO/2007/092847
Acridinium-functionalized solid-phase supports and methods for making acridinium-functionalized solid-phase supports are disclosed. The acridinium- functionalized solid-phase supports comprise a solid phase support linked to a chemilumin...  
WO/2007/092847
Acridinium-functionalized solid-phase supports and methods for making acridinium-functionalized solid-phase supports are disclosed. The acridinium- functionalized solid-phase supports comprise a solid phase support linked to a chemilumin...  
WO/2007/058568
The invention relates to 1-alkylamino-1-desoxy-polyols and 9-oxoacridine-10-acetic acid salts of general formula (I), wherein A is (II), in which R is selected from an ethyl, propyl and butyl group, to medicinal preparations containing a...  
WO/2007/058568
The invention relates to 1-alkylamino-1-desoxy-polyols and 9-oxoacridine-10-acetic acid salts of general formula (I), wherein A is (II), in which R is selected from an ethyl, propyl and butyl group, to medicinal preparations containing a...  
WO/2006/130736
The present invention relates to hydrophilic, high quantum yield acridinium compounds. It has been discovered that the placement of electron-donating groups in the acridinium ring system increases the amount of light that is emitted by t...  
WO/2006/130736
The present invention relates to hydrophilic, high quantum yield acridinium compounds. It has been discovered that the placement of electron-donating groups in the acridinium ring system increases the amount of light that is emitted by t...  
WO/2006/095139
The present invention relates to a 3,6,9 acridine compound and optionally substituted derivatives thereof that may be useful in the treatment of cancer. The invention also provides compositions comprising the compounds and uses thereof. ...  
WO/2006/092395
The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers as well as their pharmaceutically compatible salts, and to the use thereof for producing a medicament suited for treating disease...  
WO/2006/094237
Provided herein are sirtuin-modulating compounds which are derivatives of guioline or acridine and methods of use thereof . The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventin...  
WO/2006/073424
New chemiluminescent compounds, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes. Among the new acridane¬≠based compounds are water-soluble acridanes, enhancer coupled acrida...  
WO/2006/051489
Use of 1,4-bis (3-aminoalkyl) piperazine derivatives as defined in formula I or II for the manufacture of a pharmaceutical composition intended for the treatment of neurodegenerative diseases, related neurodegenerative diseases, developm...  
WO/2006/034036
The present teachings generally relate to fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes and uses thereof.  
WO/2005/121073
The present invention relates to a benzamide derivative comprising a head, spacer and cap group wherein the spacer includes a benzene ring substituted with an additional spacer and wherein the additional spacer is an unsaturated group.  
WO/2005/051296
Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r) and Plasmodium faciparum. Prodrugs of these compounds can be used as an oral tre...  
WO/2005/051915
The present invention is directed to a method of use of triazolo-pyridazine compounds in the treatment of neuropathic pain. The present invention is also directed to the use of triazolo-pyridazine compounds in the treatment of psychiatri...  
WO/2005/043124
One aspect of the invention relates to 1,8-diarylnaphthalene compounds. In certain embodiments, a compound of the invention is an N-oxide of a 1,8-diarylnaphthalene. In certain embodiments, the aryl group is an optionally substituted acr...  
WO/2005/007643
The invention relates to novel acridine derivatives of general formula (I), the production and use thereof as medicaments, in particular, for the treatment of tumours.  
WO/2004/099340
A luminescent-polymer composition comprising a luminescent polymer and ion pairs, wherein the ion pairs each has an anion having such a specific structure that the anion has one atom of a Group 13 element and is bonded to either an aryl ...  
WO/2004/091485
This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in ...  
WO/2004/092125
Substituted alkylmetal reagents such as (trimethylsilylmethyl)lithium are reacted with azaaromatic compounds and/or nitrogen heterocycle compounds to produce functionalized azaaromatic compounds and functionalized nitrogen heterocycle co...  

Matches 51 - 100 out of 563